BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12027980)

  • 21. Roles of angiogenic factors and endothelin-1 in gastric ulcer healing.
    Akimoto M; Hashimoto H; Maeda A; Shigemoto M; Yamashita K
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():450S-454S. PubMed ID: 12193143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ulcerated Leg Severity Assessment score for prediction of venous leg ulcer healing.
    Kulkarni SR; Gohel MS; Wakely C; Minor J; Poskitt KR; Whyman MR
    Br J Surg; 2007 Feb; 94(2):189-93. PubMed ID: 17205494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion.
    Howdieshell TR; Webb WL; Sathyanarayana ; McNeil PL
    Surgery; 2003 May; 133(5):528-37. PubMed ID: 12773981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the pattern of venous insufficiency influence healing of venous leg ulcers after skin transplantation?
    Kjaer ML; Jorgensen B; Karlsmark T; Holstein P; Simonsen L; Gottrup F
    Eur J Vasc Endovasc Surg; 2003 Jun; 25(6):562-7. PubMed ID: 12787700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.
    Senet P; Bon FX; Benbunan M; Bussel A; Traineau R; Calvo F; Dubertret L; Dosquet C
    J Vasc Surg; 2003 Dec; 38(6):1342-8. PubMed ID: 14681639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
    Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
    Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
    Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting time to healing by anatomical assessment of venous pathology.
    Szewczyk MT; Jawień A; Migdalski A; Piotrowicz R; Grzela T; Brazis P
    Med Sci Monit; 2009 Feb; 15(2):CR74-81. PubMed ID: 19179971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers.
    Sibbald RG; Contreras-Ruiz J; Coutts P; Fierheller M; Rothman A; Woo K
    Adv Skin Wound Care; 2007 Oct; 20(10):549-58. PubMed ID: 17906429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microcirculation disturbances in patients with venous ulcer before and after healing as assessed by laser Doppler flux-metry.
    Mlacak B; Blinc A; Gale N; Ivka B
    Arch Med Res; 2005; 36(5):480-4. PubMed ID: 16099325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel single nucleotide polymorphism of the VEGF gene as a risk predictor for gastroduodenal ulcers.
    Kim YS; Park SW; Kim MH; Jang EJ; Park JS; Park SJ; Baik HW; Chung G; Hahm KB
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S131-9. PubMed ID: 19120886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor-alfa in nonhealing venous leg ulcers.
    Charles CA; Romanelli P; Martinez ZB; Ma F; Roberts B; Kirsner RS
    J Am Acad Dermatol; 2009 Jun; 60(6):951-5. PubMed ID: 19344978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compression bandaging for venous leg ulcers: the essentialness of a willing patient.
    Annells M; O'Neill J; Flowers C
    J Clin Nurs; 2008 Feb; 17(3):350-9. PubMed ID: 18205691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calf muscle pump impairment and delayed healing of venous leg ulcers: air plethysmographic findings.
    Simka M
    J Dermatol; 2007 Aug; 34(8):537-44. PubMed ID: 17683384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
    Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
    Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of MMP-1, MMP-3 and TIMP-1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid*.
    Subramaniam K; Pech CM; Stacey MC; Wallace HJ
    Int Wound J; 2008 Mar; 5(1):79-86. PubMed ID: 18336381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ultraviolet radiation (type B) on wound exudates, appearance and depth description.
    Onigbinde AT; Adedoyin RA; Ojoawo OA; Johnson OE; Obembe AO; Olafimihan FK; Omiyale OM; Oniyangi S
    Technol Health Care; 2010; 18(4-5):297-302. PubMed ID: 21209478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.